Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05270980 · ClinicalTrials.gov registry record · NA
COVID-19 Serologic Strategies for Skilled Nursing Facilities
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 87
- Enrollment target
NCT05270980 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 87 participants.
The verdict
NCT05270980, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
Study Summary
The COVID-19 pandemic ravaged United States skilled-nursing facilities (SNFs). Novel strategies that maximize the safety and quality of life for SNF residents with ADRD and staff who care for them are urgently needed. Thus, the study's objectives are: 1. To rapidly plan and pilot test an intervention that leverages COVID-19 antibody and PCR status to pair SNF staff with residents in the safest way possible 2. To reduce reduced COVID-19 incidence rate compared to SNFs not using this novel staff-resident assignment strategy.
Interventions
- OTHER Cohorting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2021-08-11 |
| Est. Completion | 2022-02-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05270980
The ClinicalTrials.gov registry entry for NCT05270980 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cohorting is the first listed.
NCT05270980 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05270980 about?
NCT05270980 is a clinical study titled "COVID-19 Serologic Strategies for Skilled Nursing Facilities". The COVID-19 pandemic ravaged United States skilled-nursing facilities (SNFs). Novel strategies that maximize the safety and quality of life for SNF residents with ADRD and staff who care for them are urgently needed. Thus, the study's objectives are: 1. To rapidly plan and pilot test an interventi...
What is the current status of trial NCT05270980?
This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2021-08-11. Estimated completion is 2022-02-04.
What interventions are being tested in trial NCT05270980?
The interventions under investigation include: Cohorting (OTHER).
Who is sponsoring clinical trial NCT05270980?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.